Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection.
Hu Y, Paris S, Sahoo N, Bertolet G, Wang Q, Wang Q, Barsoumian HB, Da Silva J, Huang A, Doss DJ, Pollock DP, Hsu E, Selene N, Leyton CSK, Voss TA, Masrorpour F, Ganjoo S, Leuschner C, Pietz JT, Puebla-Osorio N, Gandhi S, Nguyen QN, Wang J, Cortez MA, Welsh JW.
Hu Y, et al. Among authors: doss dj.
JCI Insight. 2023 Jun 22;8(12):e167749. doi: 10.1172/jci.insight.167749.
JCI Insight. 2023.
PMID: 37345658
Free PMC article.